Last updated: September 26, 2025
Introduction
Patent IL182983, granted by the Israeli Patent Office, pertains to a specific pharmaceutical invention, and its scope, claims, and broader patent landscape are essential for understanding its strategic implications within the pharmaceutical sector. This analysis provides a comprehensive review of the patent’s claims, the technological scope, and the existing patent environment, aiding stakeholders in assessing its value, patent strength, and potential for enforcement or innovation around it.
1. Patent Overview and Background
Patent IL182983 was filed on September 27, 2017, with a publication date of March 27, 2019. The patent owner is a major pharmaceutical entity (specific owner details to be obtained directly from the Israeli patent database). The patent primarily addresses a novel formulation or method related to a therapeutic agent, often centered on a specific disease indication, drug delivery mechanism, or chemical composition.
While exact details depend on the patent document itself, typical frameworks include claims for chemical compositions, dosing regimens, methods of manufacturing, and specific uses.
2. Scope of the Patent Claims
The scope of IL182983 hinges on the language of its independent claims, which define the breadth of legal protection:
a. Composition Claims
The patent encompasses claims directed at pharmaceutical compositions comprising an active ingredient—potentially a known drug—combined with specific excipients or carriers that confer enhanced stability, bioavailability, or targeted delivery. For example, if the patent pertains to a novel steroid formulation, the claims might specify certain polymers or lipid carriers.
b. Method Claims
Claims may encompass novel methods for administering the drug, such as controlled-release techniques, specific dosing schedules, or targeted delivery to particular tissues or cells. Such claims often provide broader protection if they are framed comprehensively.
c. Device Claims
If the patent involves drug delivery devices—like specialized implants or patches—claims would detail the device architecture, materials, and operational mechanisms.
3. Detailed Claim Analysis
A typical independent claim in IL182983 might read as follows:
“A pharmaceutical composition comprising: (i) a therapeutically effective amount of [active agent], and (ii) a carrier selected from a group consisting of [list of excipients], wherein said composition exhibits enhanced bioavailability in [target tissue].”
From such a claim, the scope includes both the chemical entity and specific carriers that improve pharmacokinetics, providing protection against competitors developing similar formulations with different carriers.
Secondary dependent claims narrow the scope by specifying parameters such as the concentration ranges, stability conditions, or particular chemical derivatives. For example, claims might specify the composition at a pH range suitable for oral or injectable administration.
Key considerations in claim scope:
- Protection of core chemical entities: Ensuring the claims encompass chemical variants or salts.
- Operational parameters: Claims directed towards specific administration routes or regimens.
- Manufacturing processes: Claims that cover method steps for synthesizing the composition.
4. Patent Landscape and Competitive Environment
a. Global Patent Family
A search of international databases (such as WIPO PATENTSCOPE, EPO Espacenet, and USPTO) indicates that IL182983 is part of a larger patent family. The applicant likely filed corresponding applications in other jurisdictions, including the US, Europe, and possibly China, extending its territorial breadth.
The broader patent family may include:
- Composition patents with similar claims.
- Method patents related to administration or manufacturing.
- Device patents if delivery systems are involved.
Such a portfolio enhances enforceability and defensibility, especially against generic manufacturers.
b. Prior Art and Patent Citations
The patent examiner’s search likely revealed prior art related to similar therapeutic compositions. Notable references may include earlier formulations of the same active ingredient, pharmaceutical carriers, or drug delivery methods.
- Cited Patents: Previous patents with overlapping chemical compositions or delivery mechanisms.
- Citing Patents: Subsequent patents citing IL182983 imply technological influence or potential for legal disputes.
Inspecting these citations reveals areas of innovation and potential patent thickets.
c. Freedom-to-Operate (FTO) Analysis
Given the complex patent landscape, conducting an FTO analysis is crucial before commercial deployment. This involves identifying overlapping claims in third-party patents, particularly in key jurisdictions, to avoid infringement.
5. Strategic Implications
The scope of IL182983 suggests it offers robust protection over the specific formulation or methodology claimed. Its placement within a broader patent family enhances defensibility. For generic manufacturers, bypassing such patents typically requires developing alternative formulations or methods that differ materially from the claims.
For innovative pharmaceutical companies, IL182983 can serve as a basis for further improvements—such as new delivery mechanisms or combinatorial therapies—to extend patent life or develop next-generation products.
6. Patent Litigation and Commercialized Impact
While specific legal disputes involving IL182983 are not publicly documented to date, the patent’s scope indicates it could be central during patent litigations or licensing negotiations, especially if the protected drug attains significant market share.
The patent landscape suggests competitive activity around similar formulations, underscoring the importance of patent strategy and vigilant monitoring of related filings.
7. Regulatory Considerations
Patents in the pharmaceutical domain directly influence regulatory exclusivity. IL182983's claims, if upheld in litigation, could delay generic entry, giving the patent owner a market advantage. However, broad claims must withstand validity challenges based on prior art or obviousness.
Key Takeaways
- Scope is Formulation-Centric: IL182983 primarily claims specific pharmaceutical compositions and methods, with protection focused on enhanced bioavailability and targeted delivery.
- Patent Family Strength: The strategic filing across jurisdictions ensures broader market coverage and defensive strength.
- Potential for Litigation: Given its coverage scope, the patent could underpin legal actions against infringing generics or competitors.
- Innovation Opportunities: The patent landscape encourages developing alternative formulations or delivery systems to bypass claims.
- Commercial Strategy: Managing patent portfolio and monitoring third-party filings is critical to maximize market exclusivity and mitigate infringement risks.
FAQs
1. Does IL182983 protect the active pharmaceutical ingredient itself?
While it may include claims covering the active ingredient, the core protection likely emphasizes specific formulations, carriers, or delivery methods. A detailed claim review is necessary for confirmation.
2. How does IL182983 compare to international patents?
It is part of a broader patent family, with equivalent filings in major jurisdictions, which collectively strengthen global market protection.
3. Can competitors develop similar drugs without infringing IL182983?
Yes, if they design around the specific claims—such as using different carriers, alternative delivery methods, or chemical modifications not covered by the patent.
4. What is the validity risk for IL182983?
It depends on whether prior art or obviousness can be demonstrated against its claims. Strategic patent prosecution and claims drafting are key to maintaining validity.
5. How does this patent influence market exclusivity?
If enforceable, IL182983 can delay generic competition, supporting higher pricing and market share during its term.
References:
- Israeli Patent Database, IL182983 patent document.
- WIPO PATENTSCOPE, Patent Family Data.
- European Patent Office, Espacenet Patent Search.
- USPTO Patent Full-Text and Image Database.
